How is the uniQure N.V. today?

The uniQure N.V. today is trading in the green, up by 3.40% at 13.70.

What is uniQure N.V. Annual Revenue?

uniQure N.V. Annual Revenue rose 71.17%, in the last year to $27.12 M. Its sector's average revenue growth for the last fiscal year was 8.75%.

What is uniQure N.V. Annual Net Profit?

uniQure N.V. Annual Net Profit rose 22.34% in the last year to $239.56 M. Its sector's average net profit growth for the last fiscal year was -11.26%.

What is uniQure N.V. Price to Earning Ratio?

uniQure N.V. Price to Earning Ratio is -3.45, which is negative.

What is uniQure N.V. Stock Price?

uniQure N.V. Stock Price rose 170.22% and outperformed its sector by 161.36% in the past year.

What is uniQure N.V. Quarterly Revenue?

uniQure N.V. Quarterly Revenue fell 81.53% YoY to $1.57 M. Its sector's average revenue growth YoY for the quarter was 3.1%.

What is uniQure N.V. Quarterly Net profit?

uniQure N.V. Quarterly Net profit rose 33.5% YoY to $43.64 M. Its sector's average net profit growth YoY for the quarter was -207.11%.

What is uniQure N.V. Return on Equity(ROE)?

uniQure N.V. Return on Equity(ROE) for the last financial year was -238.46%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is uniQure N.V. Mutual Fund Holding?

uniQure N.V. Mutual Fund Holding increased by 2.81% in the last quarter to 26.26.

What is uniQure N.V. Promoter Share Holding?

uniQure N.V. Promoter Share Holding increased by 0.38% in the most recent quarter to 3.18%.

What is uniQure N.V. Interest Coverage Ratio?

uniQure N.V. Interest Coverage Ratio is -2.72, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is uniQure N.V. Institutional Holding?

uniQure N.V. Institutional Holding increased by 10.69% in the last quarter to 93.7.

uniQure N.V. XNAS: QURE

uniQure N.V. Live Share Price Today, Share Analysis and Chart

Name: uniQure N.V.: Is Infosys Ltd. worth buying?
Item: uniQure N.V.
Rating: 1.75700
Author: Trendlyne DVM scores

about

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The...

13.70 0.45 (3.40%)

27.89% Fall from 52W High

1.6M XNAS Volume

XNAS 16 May, 2025 5:30 PM (EDT)

Not Eligible

-

Expensive Valuation

3.0 / 100

Technically Moderately Bullish

67.3 / 100

35

1Yr Price target upside is 155%

11 analysts

uniQure N.V. Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

uniQure N.V. FAQ

How is uniQure N.V. today?

uniQure N.V. today is trading in the green, and is up by 3.40% at 13.70.

How has uniQure N.V. performed historically?

uniQure N.V. is currently trading up 3.40% on an intraday basis. In the past week the stock rose 7.11%. stock has been down -3.39% in the past quarter and rose 170.22% in the past year. You can view this in the overview section.